Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 23, 2024
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-01-22$65.00/sh−1,061$68,961→ 39,067 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/19/2024.